Cd20-positive B-cell Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Cd20-positive B-cell Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: A Phase 1 Study of TRS005 in Patients With R/R CD20-positive B-NHL. [Phase 1]
Phase 1 study update of TRS005 in relapsed/refractory CD20-positive B-cell Non-Hodgkin Lymphoma.
-
CLINICAL_TRIALS trial_result · 2023-04-10Clinical Trial Update: Study of IMM0306 in Patients With Relapsed or Refractory CD20-positive B-cell Non-Hodgkin's Lymphoma [Phase 1, Phase 2]
A clinical trial update for IMM0306 in relapsed or refractory CD20-positive B-cell non-Hodgkin's lymphoma across Phase 1 and Phase 2.